Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer
-
Published:2024-02-26
Issue:3
Volume:17
Page:299
-
ISSN:1424-8247
-
Container-title:Pharmaceuticals
-
language:en
-
Short-container-title:Pharmaceuticals
Author:
Hamza Shaimaa1ORCID, Garanina Ekaterina E.1, Shkair Layaly1, Alsaadi Mohammad1, Khaiboullina Svetlana F.1, Tezcan Gulcin2ORCID
Affiliation:
1. Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia 2. Department of Fundamental Sciences, Faculty of Dentistry, Bursa Uludag University, Bursa 16059, Turkey
Abstract
The NLR family pyrin domain containing 3 (NLRP3) promotes the growth of colorectal cancer (CRC). However, the therapeutic effect of NLRP3 inhibition on CRC cell progression is controversial. This study comparatively investigated the therapeutic effect of a pharmacological NLRP3 inhibitor, glibenclamide (gli), and the post-translational suppression of NLRP3 by miR-223 on CRC cell progression in HCT-116 and HCT-15 cells. LPS and ATP were used to activate Gli-treated and LSB-hsa-miR-223-3p (WTmiR-223)-expressing HCT-116 cells. NLRP3.AB.pCCL.sin.cPPT.U6.miR-223-Decoy.hPGK.GFP.WPRE plasmid (DmiR-223) was the negative control for miR-223 expression. NLRP3, gasdermin D, and BAX expressions were analyzed using western blotting. Real-time PCR detected the RNA expression of autophagy-related genes ATG5, BECN1, and miR-223 in non-transfected cells. ELISA analyzed IL-1β and IL-18 in the medium. MTS-1, annexin V, wound-healing, and sphere-invasion assays were used to assess cell viability and progression. A multiplex cytokine assay detected proinflammatory cytokine secretion. LPS–ATP-activated NLRP3 produced gasdermin D cleavage, released IL-1b and IL-18, and activated cell migration and sphere invasion. In contrast, reduced cell growth, miR-223 expression, IFN-γ, CXCL10, and LIF secretion were found in cells after inflammasome activation. Both gli and WTmiR-223 induced autophagy genes ATG5 and BECN1 and reduced the NLRP3 activation and its downstream proteins. However, while gli had a limited effect on the production of IFN-γ, CXCL10, and LIF, WTmiR-223 increased the release of those cytokines. In addition, gli did not suppress cell growth, while WTmiR-223 promoted apoptosis. Notably, neither gli nor WTmiR-223 effectively prevented sphere invasion. These data suggest that, while WTmiR-223 could have a better anticancer effect in CRC compared to gli, the sole usage of miR-223-mediated NLRP3 suppression may not be sufficient to prevent CRC metastasis.
Funder
Kazan Federal University Strategic Academic Leadership Program Russian President’s grant
Reference86 articles.
1. World Health Organization (2023, December 01). Available online: https://www.who.int/news-room/fact-sheets/detail/colorectal-cancer?gad_source=1&gclid=Cj0KCQiAxOauBhCaARIsAEbUSQRmrxLIoxqfZoy-QbAbSd1EIc_udFpS9SDysJiVxdQxohbpuY1DdIwaAjJxEALw_wcB. 2. Obesity and cancer;Calle;BMJ,2007 3. Inflammation and colon cancer;Grivennikov;Gastroenterology,2010 4. Keshavarz Shahbaz, S., Koushki, K., Ayati, S.H., Bland, A.R., Bezsonov, E.E., and Sahebkar, A. (2021). Inflammasomes and Colorectal Cancer. Cells, 10. 5. Shi, F., Wei, B., Lan, T., Xiao, Y., Quan, X., Chen, J., Zhao, C., and Gao, J. (2021). Low NLRP3 expression predicts a better prognosis of colorectal cancer. Biosci. Rep., 41.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|